Werewolf Therapeutics Inc (HOWL) USD0.0001

Sell:$1.13Buy:$1.30$0.07 (0.00%)

NASDAQ:0.32%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.13
Buy:$1.30
Change:$0.07 (0.00%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.13
Buy:$1.30
Change:$0.07 (0.00%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
162,539$0.98$159,288.226,237,482
13 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
52,974$0.98$51,914.526,074,943
12 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
320,913$0.86$275,985.186,021,969
27 March 2025
Luke B. EvninOther Level A
Sell
Option/Award related
2,425$1.05$2,546.254,309,860
27 March 2025
MPM BIOVENTURES 2014 LPVenture Capital
Sell
Option/Award related
1,963$1.05$2,061.153,208,793

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
12 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
320,913$0.86$275,985.186,021,969
14 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
162,539$0.98$159,288.226,237,482
13 May 2025
RA CAPITAL MANAGEMENT LPInvestment Management Company
Buy
Regular purchase transaction
52,974$0.98$51,914.526,074,943
27 March 2025
Luke B. EvninOther Level A
Sell
Option/Award related
2,425$1.05$2,546.254,309,860
27 March 2025
MPM BIOVENTURES 2014 LPVenture Capital
Sell
Option/Award related
1,963$1.05$2,061.153,208,793

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.